Please ensure Javascript is enabled for purposes of website accessibility
Home / Products / Antibody / Recombinant Antibody

Anti-IRS2 Antibody (R2L12)

Catalog #:   RHJ88001 Specific References (50) DATASHEET
Host species: Rabbit
Isotype: IgG
Applications: FCM, IF, IHC, WB
Accession: Q9Y4H2
Overview

Catalog No.

RHJ88001

Species reactivity

Human, Mouse, Rat

Host species

Rabbit

Isotype

IgG

Clonality

Monoclonal

Tested applications

FCM: 1:20-1:100, IF: 1:50-1:200, IHC: 1:100-1:200, WB: 1:1000-1:2000

Target

IRS2, Insulin receptor substrate 2, IRS-2

Concentration

1 mg/ml

Endotoxin level

Please contact with the lab for this information.

Purity

>95% by SDS-PAGE.

Purification

Protein A/G purified from cell culture supernatant.

Accession

Q9Y4H2

Applications

FCM, IF, IHC, WB

Form

Liquid

Storage buffer

0.01M PBS, pH 7.4, 0.05% BSA, 50% Glycerol, 0.05% Sodium azide.

Stability and Storage

Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 4 ℃ for frequent use. Store at -20 ℃ for twelve months from the date of receipt.

Clone ID

R2L12

Data Image
  • Western blot
    Western blot analysis of IRS2 expression in HEK293 cell treated with insulin.
References

Anti-OAcGD2 antibody in combination with ceramide kinase inhibitor mediates potent antitumor cytotoxicity against breast cancer and diffuse intrinsic pontine glioma cells., PMID:39395135

The IGF-Independent Role of IRS-2 in the Secretion of MMP-9 Enhances the Growth of Prostate Carcinoma Cell Line PC3., PMID:37894751

Rare ocular toxicity induced by pertuzumab/QL1209 in healthy chinese subjects: case reports and whole-exome sequencing analysis., PMID:35596833

Mast Cells and Basophils in the Defense against Ectoparasites: Efficient Degradation of Parasite Anticoagulants by the Connective Tissue Mast Cell Chymases., PMID:34884431

INitial Steps of Insulin Action in Parotid Glands of Male Wistar Rats., PMID:34345983

GLP-1 preserves β cell function via improvement on islet insulin signaling in high fat diet feeding mice., PMID:33307381

Phosphorylated and O-GlcNAc Modified IRS-1 (Ser1101) and -2 (Ser1149) Contribute to Human Diabetes Type II., PMID:32798372

Novel Somatic Genetic Variants as Predictors of Resistance to EGFR-Targeted Therapies in Metastatic Colorectal Cancer Patients., PMID:32796636

Anti-EGFR therapy in metastatic colorectal cancer: mechanisms and potential regimens of drug resistance., PMID:32665850

Distribution of Bacterial α1,3-Galactosyltransferase Genes in the Human Gut Microbiome., PMID:31998300

Immunotherapy With Antiprogrammed Cell Death 1 Antibody Improves Outcome in a Mouse Model of Spinal Cord Injury Followed by Staphylococcus aureus Pneumonia., PMID:30303841

Infliximab ameliorates tumor necrosis factor-alpha-induced insulin resistance by attenuating PTP1B activation in 3T3L1 adipocytes in vitro., PMID:30260514

Interleukin-22 level is negatively correlated with neutrophil recruitment in the lungs in a Pseudomonas aeruginosa pneumonia model., PMID:28887540

PROTECTIVE EFFECT OF CAMEL MILK AS ANTI-DIABETIC SUPPLEMENT: BIOCHEMICAL, MOLECULAR AND IMMUNOHISTOCHEMICAL STUDY., PMID:28638873

Glucocorticoid Receptor ChIP-Seq Identifies PLCD1 as a KLF15 Target that Represses Airway Smooth Muscle Hypertrophy., PMID:28375666

Single nucleotide polymorphisms in the IGF-IRS pathway are associated with outcome in mCRC patients enrolled in the FIRE-3 trial., PMID:28369940

Expression of the Tumor-associated Mucin 1 Epitope Analyzed with the Humanized PankoMab-GEX™ Antibody in Malignant and Normal Tissues of the Head and Neck., PMID:27272845

IRS2 silencing increases apoptosis and potentiates the effects of ruxolitinib in JAK2V617F-positive myeloproliferative neoplasms., PMID:26755644

Avatars Identify Genetic Sources of Drug Response., PMID:26573662

The genomic landscape of response to EGFR blockade in colorectal cancer., PMID:26416732

Insulin family polymorphisms in pregnancies complicated by small for gestational age infants., PMID:26089371

Ablation of Dicer leads to widespread perturbation of signaling pathways., PMID:26032504

P38 plays an important role in glucolipotoxicity-induced apoptosis in INS-1 cells., PMID:24734256

Insulin and metabolic stress stimulate multisite serine/threonine phosphorylation of insulin receptor substrate 1 and inhibit tyrosine phosphorylation., PMID:24652289

Insulin-dependent transcriptional control in L6 rat myotubes is associated with modulation of histone acetylation and accumulation of the histone variant H2A.Z in the proximity of the transcriptional start site., PMID:24471919

Molecular predictors of sensitivity to the insulin-like growth factor 1 receptor inhibitor Figitumumab (CP-751,871)., PMID:24107449

The consequences of long-term glycogen synthase kinase-3 inhibition on normal and insulin resistant rat hearts., PMID:23820981

Identification of the amino acids 300-600 of IRS-2 as 14-3-3 binding region with the importance of IGF-1/insulin-regulated phosphorylation of Ser-573., PMID:22912850

Conventional but not high-purity dialysis fluid induces apoptosis and insulin resistance in adipocytes in vitro., PMID:22562372

An anti-diabetes agent protects the mouse brain from defective insulin signaling caused by Alzheimer's disease- associated Aβ oligomers., PMID:22476196

Action of metformin on the insulin-signaling pathway and on glucose transport in human granulosa cells., PMID:21209036

Insulin-induced serine phosphorylation of IRS-2 via ERK1/2 and mTOR: studies on the function of Ser675 and Ser907., PMID:21098738

SIRT6 deficiency results in severe hypoglycemia by enhancing both basal and insulin-stimulated glucose uptake in mice., PMID:20847051

Molecular analysis of non-small cell lung cancer identifies subsets with different sensitivity to insulin-like growth factor I receptor inhibition., PMID:20670944

IGF activation in a molecular subclass of hepatocellular carcinoma and pre-clinical efficacy of IGF-1R blockage., PMID:20206398

Molecular predictors of response to a humanized anti-insulin-like growth factor-I receptor monoclonal antibody in breast and colorectal cancer., PMID:19671761

Association between total immunoglobulin E and antibody responses to naturally acquired Ascaris lumbricoides infection and polymorphisms of immune system-related LIG4, TNFSF13B and IRS2 genes., PMID:19604268

Insulin receptor substrate-2 in beta-cells decreases diabetes in nonobese diabetic mice., PMID:19574401

Insulin receptor substrate-2 mediated insulin-like growth factor-I receptor overexpression in pancreatic adenocarcinoma through protein kinase Cdelta., PMID:19190347

Green tea (-)-epigallocatechin gallate inhibits insulin stimulation of 3T3-L1 preadipocyte mitogenesis via the 67-kDa laminin receptor pathway., PMID:19176763

Gene silencing of phogrin unveils its essential role in glucose-responsive pancreatic beta-cell growth., PMID:19073770

Fulminant type 1 diabetes mellitus observed in insulin receptor substrate 2 deficient mice., PMID:18618219

Interleukin-10 is a protective factor against diet-induced insulin resistance in liver., PMID:18267346

Obestatin promotes survival of pancreatic beta-cells and human islets and induces expression of genes involved in the regulation of beta-cell mass and function., PMID:18162507

IL-4 protects the B-cell lymphoma cell line CH31 from anti-IgM-induced growth arrest and apoptosis: contribution of the PI-3 kinase/AKT pathway., PMID:17968425

Mammalian target of rapamycin (mTOR) inhibition activates phosphatidylinositol 3-kinase/Akt by up-regulating insulin-like growth factor-1 receptor signaling in acute myeloid leukemia: rationale for therapeutic inhibition of both pathways., PMID:17878402

Insulin-like growth factor-1 potentiates platelet activation via the IRS/PI3Kalpha pathway., PMID:17827393

Dok-1 is a positive regulator of IL-4 signalling and IgE response., PMID:17827176

Identification of a WD40 repeat-containing isoform of PHIP as a novel regulator of beta-cell growth and survival., PMID:17636024

Insulin-like growth factor receptor as a therapeutic target in head and neck cancer., PMID:17634559

Datasheet

Document Download

Anti-IRS2 Antibody (R2L12).pdf

 

$ 290
Product specifications
50 μg 290 100 μg 484

Contact Information

Order: order@antibodysystem.com

Mail: support@antibodysystem.com

Distributor list

For research use only. Not for human or drug use.

Need help with your order?

Find out more about placing an order here

Anti-IRS2 Antibody (R2L12) [RHJ88001]
Terms of sale Website terms of use Cookie policy Privacy
Copyright © 2025 AntibodySystem SAS. All Rights Reserved.            All Products are for Research Use Only